H3.3G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in Giant Cell Tumour of Bone

Glycine 34 to tryptophan (G34W) substitutions in H3.3 arise in ~90% of giant cell tumour of bone (GCT). Here, we show H3.3G34W is necessary for tumour formation. By profiling the epigenome, transcriptome and secreted proteome of patient samples and tumour-derived cells CRISPR/Cas9-edited for H3.3G34...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Discov
Autores principales: Khazaei, Sima, De Jay, Nicolas, Deshmukh, Shriya, Hendrikse, Liam D., Jawhar, Wajih, Chen, Carol C.L., Mikael, Leonie G., Faury, Damien, Marchione, Dylan M., Lanoix, Joel, Bonneil, Éric, Ishii, Takeaki, Jain, Siddhant U., Rossokhata, Kateryna, Sihota, Tianna S., Eveleigh, Robert, Lisi, Véronique, Harutyunyan, Ashot S., Jung, Sungmi, Karamchandani, Jason, Dickson, Brendan C., Turcotte, Robert, Wunder, Jay S., Thibault, Pierre, Lewis, Peter W., Garcia, Benjamin A., Mack, Stephen C., Taylor, Michael D., Garzia, Livia, Kleinman, Claudia L., Jabado, Nada
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710565/
https://ncbi.nlm.nih.gov/pubmed/32967858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-0461
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares